EMA
approval
· 2017-04-21
First medicine for spinal muscular atrophy
Summary
EMA announces the first medicine approved for spinal muscular atrophy, marking a milestone in treatment for this disease in Europe.
Upgrade for the full analysis, importance score, and drug timeline.